Pacific Biosciences Of California (PACB)
Investing Cash Flow
$156.72M
TTM · Period ending: · USD
PACB Investing Cash Flow
Latest reported$156.72Mperiod ending
Latest reported$156.72Mperiod ending
PACB TTM Cash from Investing (-$138.25M → $156.72M)
TTM investing cash flow
High-resolution chart · PNG
PACB investing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Investing Cash Flow (USD) |
|---|---|
| 156,720,000 | |
| 106,073,000 | |
| 115,448,000 | |
| 147,657,000 | |
| 151,820,000 | |
| 203,374,000 | |
| 124,004,000 | |
| -809,000 | |
| 218,449,000 | |
| 43,021,000 | |
| 4,604,000 | |
| 151,582,000 | |
| -36,833,000 | |
| 1,477,000 | |
| 116,083,000 | |
| 101,433,000 | |
| -244,121,000 | |
| -644,648,000 | |
| -678,531,000 | |
| -842,779,000 | |
| -614,774,000 | |
| -156,825,000 | |
| -219,322,000 | |
| -124,235,000 | |
| -40,935,000 | |
| -30,264,000 | |
| 62,047,000 | |
| 59,942,000 | |
| 2,939,000 | |
| 7,318,000 | |
| -38,415,000 | |
| -22,222,000 | |
| 20,005,000 | |
| -34,778,000 | |
| -1,549,000 | |
| -5,557,000 | |
| 425,000 | |
| 33,857,000 | |
| -14,864,000 | |
| -43,966,000 | |
| -40,264,000 | |
| -29,934,000 | |
| 8,606,000 | |
| 29,527,000 | |
| 27,656,000 | |
| 26,665,000 | |
| 19,564,000 | |
| -3,079,000 | |
| -12,012,000 | |
| -19,336,000 | |
| -33,117,000 | |
| 23,238,000 | |
| 35,376,000 | |
| 43,231,000 | |
| 61,792,000 | |
| 45,389,000 | |
| 52,570,000 | |
| 49,334,000 | |
| 6,446,000 | |
| -96,866,000 | |
| -122,459,000 | |
| -170,467,000 | |
| -138,250,000 | |
| -40,650,000 | |
| -29,793,000 |